Detalhe da pesquisa
1.
Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland.
Future Oncol
; 19(30): 2029-2043, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37828901
2.
Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland.
Acta Derm Venereol
; 102: adv00693, 2022 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35356995
3.
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.
Int J Cancer
; 139(8): 1883-93, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27287512
4.
Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.
Mol Ther
; 18(10): 1874-84, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20664527
5.
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform.
Mol Ther Oncolytics
; 20: 459-469, 2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718594
6.
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy.
Cancer Res
; 80(12): 2575-2585, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107211
7.
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses.
Mol Cancer Ther
; 6(10): 2728-36, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17938266
8.
Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer.
Clin Cancer Res
; 12(10): 3137-44, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16707613
9.
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 - Support for clinical studies on advanced cancer treatment.
PLoS One
; 12(8): e0182715, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28796812
10.
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers.
J Immunother Cancer
; 4: 17, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26981247
11.
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes and Th1 type polarization.
Oncoimmunology
; 3(10): e958937, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25941579
12.
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients.
Cancer Res
; 72(7): 1621-31, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22323527
13.
Serotype chimeric human adenoviruses for cancer gene therapy.
Viruses
; 2(10): 2196-2212, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21994616
14.
Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
Cancer Res
; 68(14): 5533-9, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18632604
15.
Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer.
Int J Cancer
; 121(1): 165-74, 2007 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17315187
16.
Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity.
J Gene Med
; 9(1): 3-9, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17149790
17.
Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer.
Cancer
; 107(7): 1578-88, 2006 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16948124